Nanobody: the "magic bullet" for molecular imaging?

Area of Science:

• Biomedical imaging
• Molecular biology
• Immunotechnology

Background:

• Molecular imaging enables in vivo study of biological processes for disease understanding and treatment.
• Nanobodies, engineered single-domain antibody fragments, are emerging tools in molecular imaging.
• Their small size and unique binding characteristics offer advantages over traditional agents.

Purpose of the Study:

• To review recent advancements in nanobody-based probes for molecular imaging.
• To highlight the potential of nanobodies in visualizing disease-related targets.
• To discuss the application of nanobodies across various imaging modalities.

Main Methods:

• Literature review of nanobody engineering and application in molecular imaging.
• Analysis of nanobody properties relevant to imaging (size, stability, targeting).
• Summary of studies utilizing nanobody probes in radionuclide, optical, and ultrasound imaging.

Main Results:

• Nanobodies exhibit desirable features for imaging, including rapid targeting and clearance, high solubility, and stability.
• Nanobody-based probes have been successfully applied in various preclinical disease models.
• Diverse imaging techniques have employed nanobody probes for target visualization.

Conclusions:

• Nanobody-based molecular imaging agents demonstrate significant preclinical promise.
• These agents are expected to play a crucial role in disease diagnosis and management.
• Further development of nanobody probes will advance molecular imaging capabilities.